Lafrost
Lafrost Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Lafrost is a brand name. Its generic name is Docosanol.
What is Lafrost
Lafrost is an antiviral cream used to treat cold sores (oral herpes) caused by the herpes simplex virus. It works by blocking the ability of the herpes virus to penetrate healthy skin cells, thus preventing infection and reducing symptoms. It is available as a brand called Abreva.Uses for Lafrost
Lafrost is primarily used for the treatment of cold sores. It can be used as soon as symptoms appear and should be applied five times a day for four days or until the sore is healed. It is also used as a preventative measure to prevent cold sores from forming when exposed to triggers such as sunlight, fever, or stress.Mechanism of Action
Lafrost works by forming a protective barrier on the surface of the skin. This barrier blocks the ability of the herpes virus to attach to, and penetrate, healthy skin cells. Without the ability to penetrate and replicate in healthy cells, the virus is unable to spread and cause infection. Lafrost also helps to reduce inflammation and redness associated with cold sores.How Long Does it Take to Work
When applied at the first sign of cold sore symptoms, Lafrost usually begins to reduce symptoms within 2-3days. However, it may take up to 4 days for the full effect to be achieved.Absorption
When applied topically, Lafrost is well absorbed through the skin. Systemic absorption is minimal but some inactive metabolites may be detectable in the plasma.Route of Elimination
Lafrost is eliminated from the body primarily through the urine.Dosage
The usual dose of Lafrost for the treatment of cold sores is 10% cream applied onto the affected area 5 times a day for up to 4 days or until the sore is healed. The cream should be applied to the affected area as soon as symptoms are present.Administration
Lafrost should be applied topically to the affected area. It should be used as soon as symptoms appear and should be applied 5 times a day until the sore is healed or until 24-hours have passed since the last application.Side Effects
The most common side effect of Lafrost is skin irritation or dryness at the application site. This can include redness, itching, or burning. If these side effects persist or worsen, contact your doctor or pharmacist.Toxicity
No meaningful toxicity has been reported with the use of Lafrost.Precaution
Lafrost should not be used on broken, irritated, or raw skin. It should not be used in the eyes, mouth, or nose, or on genital herpes sores. Do not apply more of the drug than prescribed. Avoid applying the medication when the skin is exposed to direct sunlight, heat, or cold.Interaction
Lafrost is not known to interact with any other medications or substances.Disease Interactions
Lafrost is not known to interact with any diseases or conditions. However, it should not be used on broken, irritated, or raw skin.Drug Interactions
Lafrost is not known to interact with any other drugs or medications. However, it should not be used at the same time as other topical medications.Food Interactions
Lafrost is not known to interact with any foods or beverages.Pregnancy Use
Lafrost should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus.Lactation Use
Lafrost is excreted in milk, and should be used with caution in women who are breastfeeding.Acute Overdose
No information is available regarding acute overdose with Lafrost.Contraindication
Lafrost should not be used on broken, irritated, or raw skin. It should not be used in the eyes, mouth, or nose, or on genital herpes sores.Use Direction
Lafrost should be applied topically to the affected area at the first sign of cold sore symptoms. The cream should be applied 5 times a day, until the sore is healed or until 24 hours have passed since the last application.Storage Condition
Lafrost should be stored at room temperature, away from light and moisture.Volume of Distribution
No information is available on the volume of distribution of Lafrost.Half Life
No information is available on the half-life of Lafrost.Clearance
No information is available on the clearance of Lafrost.Here you find in details version of Lafrost
Some Frequently Asked Questions About Lafrost
https://www.medicinesfaq.com/brand/lafrost,
http://classyfire.wishartlab.com/tax_nodes/C0000000,
http://classyfire.wishartlab.com/tax_nodes/C0000012,
http://classyfire.wishartlab.com/tax_nodes/C0003909,
http://classyfire.wishartlab.com/tax_nodes/C0001334,
http://classyfire.wishartlab.com/tax_nodes/C0001334,
http://classyfire.wishartlab.com/tax_nodes/C0000286,
http://classyfire.wishartlab.com/tax_nodes/C0004150,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31000,
http://www.lipidmaps.org/data/LMSDRecord.php?LMID=LMFA05000008,
http://metacyc.org/META/new-image?type=COMPOUND&object=CPD-7845,
http://www.hmdb.ca/metabolites/HMDB0014770,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=12620,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46508049,
https://www.chemspider.com/Chemical-Structure.12100.html,
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239998,
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=594680,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=31000,
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1200453,
https://zinc.docking.org/substances/ZINC000006920384,
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP001249,
http://www.pharmgkb.org/drug/PA164749211,
https://www.drugs.com/cdi/docosanol.html,
https://en.wikipedia.org/wiki/Docosanol,